Vulnerabilities

Vulnerability · CVE-2022-4992

Dräger Infinity Acute Care System and Standalone Infinity M540 patient monitors versions VG4.1.1, VG4.0.3, and lower (with VG4.2 partially affected) contain a network…

Published Jun 2, 2026 · catalog updated Jul 22, 2026 · the affected product

Check if you run it

No confirmed exploitation is on record for CVE-2022-4992. EPSS is 0.16%. Act only if a listed version of the affected product is installed.

Gaps on this record

  • No plain product name is stored. The page cannot tell you which product to check.
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High8.8
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.16%
Remediation
Advisory link
Affected products
See sources for product scope

Dräger Infinity Acute Care System and Standalone Infinity M540 patient monitors versions VG4.1.1, VG4.0.3, and lower (with VG4.2 partially affected) contain a network message handling vulnerability that allows remote attackers to inject spoofed or tampered data and cause denial-of-service conditions. Attackers can compromise network communications to modify device settings such as alarm states or alarm limits, or overwhelm the system with excessive network traffic causing the Cockpit or M540 to reboot and lose network functionality.

No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.

How to fix CVE-2022-4992

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2022-4992. EPSS is 0.16%. Act only if a listed version of the affected product is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-345: Insufficient Verification of Data Authenticity. EPSS 0.16%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Jun 2, 2026 · NIST NVD

    Detected

    Dräger Infinity Acute Care System and Standalone Infinity M540 patient monitors versions VG4.1.1, VG4.0.3, and lower (with VG4.2 partially affected) contain a network message handling vulnerability that allows remote attackers to inject spoofed or tampered data and cause denial-of-service conditions. Attackers can compromise network communications to modify device settings such as alarm states or

  2. Jul 22, 2026 · NIST NVD

    Updated

    Dräger Infinity Acute Care System and Standalone Infinity M540 patient monitors versions VG4.1.1, VG4.0.3, and lower (with VG4.2 partially affected) contain a network message handling vulnerability that allows remote attackers to inject spoofed or tampered data and cause denial-of-service conditions. Attackers can compromise network communications to modify device settings such as alarm states or

Sources

  • CVE.orgVulnerability recordCVE-2022-4992

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2022-4992

    30-day exploitation probability 0.16%

    first.org
  • NIST NVDVulnerability recordCVE-2022-4992

    Dräger Infinity Acute Care System and Standalone Infinity M540 patient monitors versions VG4.1.1, VG4.0.3, and lower (with VG4.2 partially affected) contain a network message handling vulnerability that allows remote attackers to inject spoofed or tampered data and cause denial-o

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 24, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.